ZBH makes small acquisition in tissue healing: https://finance.yahoo.com/news/zimmer-biomet-acquire-embody-inc-120000718.html Zimmer Biomet Holdings, Inc., a global medical technology leader, today announced that it has reached a definitive agreement to acquire Embody, Inc., a privately-held medical device company focused on soft tissue healing, for $155 million at closing and up to an additional $120 million subject to achieving future regulatory and commercial milestones over a three year period. The acquisition is expected to be accretive to overall revenue growth and slightly dilutive to adjusted earnings per share in 2023.Although this deal is on the small side, it’s significant, IMO, in that ZBH finally feels that its COVID-related issues are behind it.